192 related articles for article (PubMed ID: 20625082)
1. Intermittent hypoxia increases arterial blood pressure in humans through a Renin-Angiotensin system-dependent mechanism.
Foster GE; Hanly PJ; Ahmed SB; Beaudin AE; Pialoux V; Poulin MJ
Hypertension; 2010 Sep; 56(3):369-77. PubMed ID: 20625082
[TBL] [Abstract][Full Text] [Related]
2. Losartan abolishes oxidative stress induced by intermittent hypoxia in humans.
Pialoux V; Foster GE; Ahmed SB; Beaudin AE; Hanly PJ; Poulin MJ
J Physiol; 2011 Nov; 589(Pt 22):5529-37. PubMed ID: 21930596
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.
Morgan BJ; Teodorescu M; Pegelow DF; Jackson ER; Schneider DL; Plante DT; Gapinski JP; Hetzel SJ; Dopp JM
Exp Physiol; 2018 Jul; 103(7):941-955. PubMed ID: 29750475
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea.
Beaudin AE; Pun M; Yang C; Nicholl DD; Steinback CD; Slater DM; Wynne-Edwards KE; Hanly PJ; Ahmed SB; Poulin MJ
J Am Heart Assoc; 2014 May; 3(3):e000875. PubMed ID: 24815497
[TBL] [Abstract][Full Text] [Related]
5. Losartan reduces the immediate and sustained increases in muscle sympathetic nerve activity after hyperacute intermittent hypoxia.
Jouett NP; Moralez G; Raven PB; Smith ML
J Appl Physiol (1985); 2017 Apr; 122(4):884-892. PubMed ID: 28082332
[TBL] [Abstract][Full Text] [Related]
6. Intermittent hypoxia reduces cerebrovascular sensitivity to isocapnic hypoxia in humans.
Querido JS; Godwin JB; Sheel AW
Respir Physiol Neurobiol; 2008 Mar; 161(1):1-9. PubMed ID: 18206428
[TBL] [Abstract][Full Text] [Related]
7. [Role of the renin-angiotensin system on the sympathetic response induced by the cold pressor test in humans].
Zavala LE; Cierco M; Gutiérrez A; Garrido MR; Israel A
Invest Clin; 2007 Jun; 48(2):155-65. PubMed ID: 17598639
[TBL] [Abstract][Full Text] [Related]
8. Renin activity and blood pressure in response to chronic episodic hypoxia.
Fletcher EC; Bao G; Li R
Hypertension; 1999 Aug; 34(2):309-14. PubMed ID: 10454459
[TBL] [Abstract][Full Text] [Related]
9. [Changes of angiotensin II and its receptor during the development of chronic intermittent hypoxia-induced hypertension in rats].
Yuan ZM; Chen BY; Wang PX; Li SY; Chen YL; Dong LX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):577-80. PubMed ID: 15498265
[TBL] [Abstract][Full Text] [Related]
10. Impact of intermittent hypoxia on human vascular responses during sleep.
Beaudin AE; Hanly PJ; Raneri JK; Younes M; Pun M; Anderson TJ; Poulin MJ
Exp Neurol; 2022 Jan; 347():113897. PubMed ID: 34655575
[TBL] [Abstract][Full Text] [Related]
11. Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked.
Derad I; Sayk F; Lehnert H; Marshall L; Born J; Nitschke M
Hypertension; 2014 Apr; 63(4):762-7. PubMed ID: 24420549
[TBL] [Abstract][Full Text] [Related]
12. Moment-to-moment characteristics of the relationship between arterial pressure and renal interstitial hydrostatic pressure.
Komolova M; Adams MA
Hypertension; 2010 Oct; 56(4):650-7. PubMed ID: 20696984
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1995 Jul; 13(1):S23-8. PubMed ID: 18800452
[TBL] [Abstract][Full Text] [Related]
14. The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets.
Camelo JS; Hehre D; Devia C; Camelo SH; Bancalari E; Suguihara C
Neonatology; 2008; 93(4):263-8. PubMed ID: 18043007
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans.
Foster GE; Brugniaux JV; Pialoux V; Duggan CT; Hanly PJ; Ahmed SB; Poulin MJ
J Physiol; 2009 Jul; 587(Pt 13):3287-99. PubMed ID: 19417094
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system and the effect of propranolol upon the cerebral cortical and hypothalamic circulation in hypoxia.
Olteanu A; Grosu L; Vlasie N; Pavel T; Barabas E; Baciu I
Rom J Physiol; 1997; 34(1-4):25-33. PubMed ID: 9653807
[TBL] [Abstract][Full Text] [Related]
18. Short-Term Angiotensin Subtype 1 Receptor Blockade Does Not Alter the Circulatory Responses to Sympathetic Nervous System Modulation in Healthy Volunteers Before and During Sevoflurane Anesthesia: Results of a Pilot Study.
Arain SR; Freed JK; Novalija J; Pagel PS; Ebert TJ
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1479-1484. PubMed ID: 27751762
[TBL] [Abstract][Full Text] [Related]
19. The effect of two different intermittent hypoxia protocols on ventilatory responses to hypoxia and carbon dioxide at rest.
Koehle M; Sheel W; Milsom W; McKenzie D
Adv Exp Med Biol; 2008; 605():218-23. PubMed ID: 18085275
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure, magnesium and other mineral balance in two rat models of salt-sensitive, induced hypertension: effects of a non-peptide angiotensin II receptor type 1 antagonist.
Rondón LJ; Marcano E; Rodríguez F; del Castillo JR
Magnes Res; 2014; 27(3):113-30. PubMed ID: 25560239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
